Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
First Light Capital Group is a women-led venture capital and investment firm focused on supporting female entrepreneurs, primarily in the technology and pharmaceutical industries. The group provides seed funding and support for women-led businesses with innovative ideas, including those in life sciences and healthcare[2][7].
The founder, Alba Tull, also runs Tull Investment Group and has philanthropic ties to medical innovation through the University of Pittsburgh School of Medicine. The firm's investments include both public/private equities and debt using proprietary analytics[2]. Recent investments include Takumi Giken Industry (Series A)[7].
While First Light Capital Group itself does not have clinical programs or products, it invests in early-stage companies that may be developing new therapies or technologies within pharma/biotech/healthcare sectors[2][7].
It should be noted there are several similarly named entities (e.g., "Firstlight Bio," "FirstLight Asset Management," "FIRSTLIGHT Capital" VC), but these are distinct from First Light Capital Group[5][3][4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on First Light Capital Group.